Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 28% ± 6% | |
oligodendrocyte | 4 studies | 26% ± 4% | |
GABAergic neuron | 3 studies | 21% ± 3% | |
glutamatergic neuron | 3 studies | 24% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1666.24 | 2642 / 2642 | 100% | 24.54 | 702 / 705 |
ovary | 81% | 269.38 | 145 / 180 | 27% | 0.79 | 115 / 430 |
esophagus | 61% | 349.66 | 885 / 1445 | 40% | 2.16 | 73 / 183 |
uterus | 65% | 203.48 | 111 / 170 | 30% | 1.81 | 139 / 459 |
pancreas | 56% | 134.62 | 184 / 328 | 30% | 0.57 | 54 / 178 |
adrenal gland | 40% | 113.34 | 103 / 258 | 42% | 1.87 | 96 / 230 |
prostate | 49% | 159.81 | 119 / 245 | 27% | 0.45 | 138 / 502 |
lung | 29% | 92.61 | 168 / 578 | 35% | 2.04 | 408 / 1155 |
intestine | 49% | 161.56 | 471 / 966 | 5% | 0.14 | 26 / 527 |
blood vessel | 46% | 273.30 | 616 / 1335 | 0% | 0 | 0 / 0 |
skin | 0% | 1.10 | 7 / 1809 | 40% | 1.52 | 188 / 472 |
heart | 39% | 188.19 | 335 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 23% | 0.85 | 18 / 80 |
breast | 3% | 7.20 | 16 / 459 | 19% | 0.48 | 212 / 1118 |
bladder | 10% | 18.57 | 2 / 21 | 12% | 0.55 | 60 / 504 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.40 | 7 / 45 |
stomach | 6% | 11.50 | 21 / 359 | 7% | 0.23 | 20 / 286 |
kidney | 0% | 0 | 0 / 89 | 9% | 0.22 | 79 / 901 |
peripheral blood | 8% | 23.23 | 78 / 929 | 0% | 0 | 0 / 0 |
spleen | 7% | 14.11 | 16 / 241 | 0% | 0 | 0 / 0 |
thymus | 1% | 1.44 | 4 / 653 | 5% | 0.24 | 33 / 605 |
liver | 0% | 0 | 0 / 226 | 5% | 0.23 | 22 / 406 |
adipose | 3% | 8.98 | 41 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006656 | Biological process | phosphatidylcholine biosynthetic process |
GO_0007283 | Biological process | spermatogenesis |
GO_0001541 | Biological process | ovarian follicle development |
GO_0006657 | Biological process | CDP-choline pathway |
GO_0005737 | Cellular component | cytoplasm |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0031210 | Molecular function | phosphatidylcholine binding |
GO_0004105 | Molecular function | choline-phosphate cytidylyltransferase activity |
Gene name | PCYT1B |
Protein name | Choline-phosphate cytidylyltransferase B (EC 2.7.7.15) (CCT-beta) (CTP:phosphocholine cytidylyltransferase B) (CCT B) (CT B) (Phosphorylcholine transferase B) choline-phosphate cytidylyltransferase (EC 2.7.7.15) |
Synonyms | CCTB |
Description | FUNCTION: [Isoform 1]: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. .; FUNCTION: [Isoform 2]: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . |
Accessions | ENST00000496020.1 Q9Y5K3 ENST00000356768.8 [Q9Y5K3-2] ENST00000379145.5 [Q9Y5K3-4] ENST00000379144.7 [Q9Y5K3-1] F2Z2B1 |